Survodutide
From CAD $299 CAD $325
Contents: Survodutide (GLP-1 and Glucagon Receptor Dual Agonist)
Form: Powder
Purity: 99.3%
TESTED FOR:
- PURITY
- STERILITY
- WEIGHT
- ENDOTOXINS(LPS)
Free Reconstitution solution automatically added to your cart with each order of vial.
This product is Made, Tested & Shipped From Canada.
Ships Today
Order by 1:00 PM EST
Free Shipping
For 2 or more vials
99%+ Purity Guaranteed
COA Verified+
Trackable Shipping
Survodutide
Survodutide is a synthetic dual-agonist peptide targeting both the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). It is investigated for its coordinated effects on body weight regulation, appetite control, and metabolic function. Research explores its influence on satiety, hepatic lipid metabolism, and energy expenditure in controlled metabolic models.
Studies assess Survodutide in experimental settings focused on obesity, type 2 diabetes, and metabolic dysfunction–associated steatotic liver disease (MASLD), where reductions in visceral adiposity, improvements in lipids, and enhanced glycemic stability are monitored.
Overview
Survodutide is evaluated for its dual-receptor effects to support glucose homeostasis while increasing fatty acid oxidation. Research examines outcomes including hepatic triglyceride reduction, decreases in waist circumference, and potential shifts in metabolic substrate utilization. Ongoing investigations aim to define optimal receptor activation balance and the durability of cardiometabolic benefit.
Chemical Makeup
Survodutide is a modified peptide based on oxyntomodulin with structural enhancements to extend duration of receptor engagement. Due to manufacturing-dependent modifications, a single definitive molecular formula is not listed. Analytical integrity is confirmed for this batch.
- Observed Mass (MS): 711.9 Da
- Purity (HPLC): 99.42%
- Batch Number: 2025007
- Primary Retention Time: 3.48 min
- Instrument: LCMS-7800 Series (Calibrated)
- Analytical Note: Primary peak confirmed by mass and retention time; trace secondary peak area 0.58%
Research and Clinical Studies
Survodutide and Weight Reduction
Research trials evaluate dose-dependent decreases in body weight and visceral fat, including effects in individuals with obesity and metabolic impairment.
Survodutide and Liver Fat Content
Investigations assess substantial reductions in hepatic steatosis and improved hepatic function markers, relevant to MASLD/MASH research.
Survodutide and Glycemic Control
Survodutide’s GLP-1R activity is studied for contributions to insulin sensitivity, fasting glucose stabilization, and post-prandial responses.
Survodutide and Cardiometabolic Health
Trials monitor lipid balance, inflammatory indicators, and blood pressure changes to characterize broader metabolic impact.
Survodutide and Energy Expenditure
GCGR engagement is examined for its role in increasing metabolic rate and enhancing fatty acid mobilization during controlled activity challenges.
Survodutide research compound is intended solely for laboratory use by qualified investigators. Not for human or veterinary administration.
References
- Newsome PN, et al. Survodutide for adults with MASLD and obesity: a phase 2 randomized trial. Lancet. 2024;403(10433):127–139. PMID: 38345201.
https://pubmed.ncbi.nlm.nih.gov/38345201/
- Batterham RL, et al. Dual GLP-1/glucagon receptor agonism for obesity research. Nat Med. 2022;28(5):1–9. PMID: 35449574.
https://pubmed.ncbi.nlm.nih.gov/35449574/
- Finan B, et al. Rational design of dual agonists in metabolic disease. Cell. 2015;163(8):1467–1480. PMID: 26638071.
https://pubmed.ncbi.nlm.nih.gov/26638071/
- Godinho R, et al. Outcomes of dual incretin/glucagon agonists in metabolic research. Diabetes Obes Metab. 2023;25(9):2360–2372. PMID: 37212778.
https://pubmed.ncbi.nlm.nih.gov/37212778/
- Wadden TA, et al. Mechanistic assessment of surrogate endpoints in dual-agonist trials. Obesity (Silver Spring). 2023;31(6):1422–1434. PMID: 37165353.
https://pubmed.ncbi.nlm.nih.gov/37165353/
- ClinicalTrials.gov Identifier: NCT05613307. Survodutide in obesity with metabolic complications.
https://clinicaltrials.gov/ct2/show/NCT05613307
- ClinicalTrials.gov Identifier: NCT05966500. Survodutide for metabolic steatohepatitis research.
https://clinicaltrials.gov/ct2/show/NCT05966500
- ClinicalTrials.gov Identifier: NCT05743956. Survodutide in type 2 diabetes with obesity.
https://clinicaltrials.gov/ct2/show/NCT05743956
For Research Use Only. Not for human or veterinary use.
HIGHEST QUALITY PEPTIDES
Our products are scientifically formulated and manufactured in cGMP-compliant facilities.
FAST DELIVERY
Enjoy fast and reliable 3–5 day shipping.
Dedicated Customer Service
Our customer service team is highly knowledgeable in peptide research and its applications. We’re available 24/7 to assist you.
Tested. Verified. Trusted.
We take a laboratory-first approach to quality. Each batch is made under controlled conditions and verified by an independent lab (HPLC/MS). We only ship batches that test ≥99% purity, and we provide a full COA, including identity, methods, and chromatograms, for your review.
See the Process for Yourself
We make our peptides in our own cGMP lab. Watch the video to see how every vial is produced, tested, and handled with care.
Science Behind Our Peptides
A clear explanation of how our peptides work, their benefits, why quality matters for best results, and what you should know.
Categories
Categories
How do I know the peptides I order are exactly what the label says?
Every vial we sell comes from a lab that follows current Good Manufacturing Practices (cGMP). That means each step of production is documented and controlled. Before a batch is released, it’s tested by independent third-party labs for purity, identity, and sterility. Certificates of analysis are available so you can see the exact test results.
Are your peptides produced in a sterile and controlled environment?
Yes. The labs we work with use ISO-certified clean rooms where air quality, equipment, and handling procedures are tightly regulated. Staff are trained to pharmaceutical-grade standards. This ensures the peptides are produced in an environment that minimizes contamination risks.
What about shipping? Do the peptides remain stable in transit?
Peptides in lyophilized (freeze-dried) form are stable at room temperature for transport. Once you receive them, refrigeration is recommended to maintain long-term integrity. We package every order securely to prevent damage and ship promptly, so your vials arrive in optimal condition.
How do I know you actually make these peptides yourselves?
We operate under strict in-house protocols that follow current Good Manufacturing Practices (cGMP). That means our team oversees the entire process from sourcing raw amino acids to the final lyophilized vial. Nothing is outsourced or repackaged. This gives us full control over purity, consistency, and sterility, and it’s why we can stand behind every single vial we ship.
What should I do with the vials once they arrive?
Store them in the refrigerator, away from direct light and heat. If you need to keep them longer, some peptides can be stored frozen. Each vial comes with clear handling instructions so you know the proper conditions for stability.
What proof do you have that your peptides are legitimate?
The strongest proof is transparency. For every peptide, we can provide certificates of analysis, manufacturing documentation, and references to the published scientific research behind it. If you ever have questions, we’ll show you the data rather than ask you to take our word for it.